- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
There is no shortage of opinions and politics as the House prepares for a vote Nov. 30 on 21st Century Cures Act.
The news that Translarna will remain on the European market for at least five more years sent PTC Therapeutics shares soaring.
More about Vertex' Debbie Downer gene, Biogen's Alzheimer's spin and Sarepta caught in drug launch purgatory.